Hyderabad India May 4th, 2024: Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”), today announced its launch
The post Dr. Reddy’s Laboratories announces the launch of Doxycycline Capsules, 40 mg* in the U.S. appeared first on Smart Business News.